focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFLX.L Regulatory News (FLX)

  • There is currently no data for FLX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Contract Win and Directorate Change

15 Jan 2018 08:37

RNS Number : 8525B
Falanx Group Limited
15 January 2018
 

 

Falanx Group Limited

("Falanx" or "the Company")

 

Contract Win and Directorate Change

 

Falanx (AIM:FLX), the global intelligence, security and cyber defence provider, announces a multi-year contract win and the appointment of a new Chief Financial Officer (CFO).

 

Contract Win

 

The Board is pleased to announce winning a new 3-year managed Cyber Security service contract with a premier UK Health Sector organisation, which has been a valued client of Falanx for over two years. This will generate in excess of £250,000 of revenues for Falanx during the course of the contract, further improving visibility of forward earnings.

 

This valued client of over two years, now enjoys the benefit of all the Falanx product offerings of Assess, Consult, Monitor and Response. This new contract provides an expansion of our Protective Monitoring service to provide more comprehensive coverage of the IT estate.

 

In addition, the Falanx Cyber 'Incident Response' service will provide 24/7 coverage to contain and protect infrastructure in the event of a breach or data leakage. This extension of cover allows the Falanx team to immediately isolate the part of the network that has been detected as compromised from within the Falanx SOC (Security Operations Centre), whilst remediation takes place.

 

Appointment of Ian Selby as Chief Financial Officer

Ian has been appointed to the Board with effect from 15th January 2018 and is a Chartered Accountant with significant experience in the technology, security and business services sectors. He was previously the CFO of AIM listed Westminster Group plc where he supported the development of their successful managed services business and the raising of the associated financing. Before this he was Group Finance Director of Zenith Hygiene Group plc, where he was instrumental in executing a successful trade sale and prior to this was the CFO of a listed software company focused on financial and public sectors.

Ian has extensive experience including due diligence, M&A, fundraising, working capital improvements, bank and mezzanine debt, and operational finance management. Earlier in his career he held international finance roles in listed technology companies including Halliburton Inc, Sybase Inc and Micro Focus plc. He qualified as a Chartered Accountant with Coopers & Lybrand Deloitte and holds a degree in Physics from the University of Birmingham.

Pursuant to Rule 17 and Schedule 2(g) of the AIM Rules for Companies, the following information is disclosed in respect of Ian Robert Selby aged 51.

Current Appointments

IRS Consulting Ltd

Appointments in the last 5 years

 

Westminster Group PLC

Westminster Aviation Security Services Ltd

Westminster International Ltd

Westminster Operating Ltd

Westminster Facilities Management Ltd

Westminster JV Holdings Ltd

Sovereign Ferries Ltd

CTAC Ltd

Longmoor Security Ltd

Amba Defence Solutions Ltd

Amba Defence Control Ltd

Rapid Support Platforms Ltd

Travel Safety & Security Ltd

 

There are no further disclosures to be made under Schedule 2(g) of the AIM Rules for Companies.

Mike Read, Chairman and CEO, commented:

 

"I am delighted to report the extension and increase of services to one of our most valued clients in the Health Sector. This further demonstrates our ability to successfully migrate clients consuming traditional cyber test and consultancy services into managed monitoring of their network with our proprietary platform and on-call response.

 

I am also very pleased to welcome Ian Selby to our team. Ian comes with an extremely strong background in assisting the development of successful businesses and knowledge of AIM. I am sure he will be an extremely valued and influential member of our team as we continue to grow."

 

Issue of Equity and Warrants

 

Under the terms of the Joint Brokership announced on 13 September 2017 the Company has issued 166,667 new ordinary shares ("Ordinary Shares") and the Warrants described below in the Company at a price of 7.5 pence each to Beaufort Securities Limited as consideration for corporate broking fees.

 

Application will be made for the Ordinary Shares to be admitted to trading on AIM and dealings in these shares are expected to commence on 18 January 2018.

 

The new Ordinary Shares will rank pari passu with the existing Ordinary Shares in issue. Following Admission, the Company's total issued share capital will comprise 157,456,742 Ordinary Shares. This number may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules

The Company has issued the following warrants to Beaufort Securities:

 

1. 250,000 warrants with exercise price of 10p with 3 year life (exercisable if share price exceeds 15p for 3 months)

2. 250,000 warrants with exercise price of 15p with 3 year life (exercisable if share price exceeds 20p for 3 months)

3. 250,000 warrants with exercise price of 20p with 3 year life (exercisable if share price is above 25p for 3 months)

 

 

Enquiries:

 

Falanx Group Limited

Mike Read, Chairman and CEO

 

www.falanx.com

 

SPARK Advisory Partners Limited

Nominated Adviser

Matt Davis / James Keeshan

+44 (0) 203 368 3551

 

Turner Pope Investments (TPI) Ltd

Joint-Broker

Ben Turner / James Pope

 

Beaufort Securities

Joint-Broker

Elliot Hance

 

IFC Advisory Ltd

Financial PR & IR

Graham Herring

Miles Nolan

+44 (0) 203 621 4120

 

 

 

+44 (0) 207 382 8300

 

 

 

+44 (0) 203 934 6630

 

About Falanx

Falanx Group Limited, is a global intelligence and cyber defence provider working with blue chip and government clients. The Group listed on AIM in June 2013 under ticker FLX For more information: http://www.falanxgroup.com/

 

MAR

This announcement contains inside information for purposes of Article 7 of Regulation (EU) No 596/2014

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCVELBFVFFXBBE
Date   Source Headline
9th Dec 20222:42 pmRNSHolding(s) in Company
8th Dec 20224:29 pmRNSResult of AGM
8th Dec 20227:00 amRNSInterim Results
24th Nov 20225:17 pmRNSHolding(s) in Company
15th Nov 20225:56 pmRNSNotice of AGM
18th Oct 20227:00 amRNSDirectorate Change
29th Sep 20227:00 amRNSFinal Results
20th Sep 20227:00 amRNSHolding(s) in Company
5th Sep 20224:53 pmRNSHolding(s) in Company
4th Aug 20222:06 pmRNSSecond Price Monitoring Extn
4th Aug 20222:00 pmRNSPrice Monitoring Extension
4th Aug 202211:05 amRNSSecond Price Monitoring Extn
4th Aug 202211:00 amRNSPrice Monitoring Extension
4th Aug 20227:00 amRNSTrading Update
9th May 20227:00 amRNSPartnership to Provide M-EDR to UK Customers
8th Apr 20224:06 pmRNSHolding(s) in Company
6th Apr 202211:59 amRNSHolding(s) in Company
1st Apr 20227:00 amRNSChange of Adviser
30th Mar 20222:44 pmRNSDirector/PDMR Shareholding
23rd Mar 202212:59 pmRNSDirector/PDMR Shareholding
10th Feb 202211:11 amRNSDirector/PDMR Shareholding
24th Jan 20227:00 amRNSDirector/PDMR Shareholding
19th Jan 20225:20 pmRNSHolding(s) in Company
19th Jan 20227:00 amRNSDirector/PDMR Shareholding
7th Dec 202111:14 amRNSResult of AGM
7th Dec 20217:00 amRNSInterim Results
16th Nov 20212:10 pmRNSNotice of AGM
29th Oct 20211:57 pmRNSExercise of Options, TVR and PDMR dealing
27th Oct 20219:03 amRNSDirector/PDMR Shareholding
26th Oct 20217:00 amRNSDirector/PDMR Shareholding
25th Oct 20213:25 pmRNSExercise of Options and TVR
13th Oct 202111:06 amRNSSecond Price Monitoring Extn
13th Oct 202111:00 amRNSPrice Monitoring Extension
13th Oct 20217:00 amRNSTrading update and BOOST&Co loan facility update
6th Oct 20214:41 pmRNSSecond Price Monitoring Extn
6th Oct 20214:35 pmRNSPrice Monitoring Extension
6th Oct 20212:43 pmRNSSale of Assynt for £4.6 million
4th Oct 20217:00 amRNSFalanx Launch Mass Market Security Assessment Tool
29th Sep 20217:00 amRNSAnnual results for the year ended 31 March 2021
18th Aug 20217:01 amRNSGrant of share options
18th Aug 20217:00 amRNSTrading Update & New Loan Facility
9th Jul 20219:07 amRNSHolding(s) in Company
29th Apr 20217:00 amRNSCancellation of unapproved Share Options
1st Apr 20217:00 amRNSIssue of Equity and TVR
26th Feb 20213:31 pmRNSResult of GM
10th Feb 20212:03 pmRNSPublication of Circular & Notice of GM
8th Feb 202111:05 amRNSSecond Price Monitoring Extn
8th Feb 202111:00 amRNSPrice Monitoring Extension
5th Feb 20217:00 amRNSContract Wins and Covid Business Interruption Loan
18th Jan 20212:06 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.